Lynch Casey
SEC CIK 1770783 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | CEO, Dir | 109.9K | — | — | 1 | 2021-11-18 | 2021-11-18 |
Most active insiders at QNCX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Benatti Luca | Dir | — | $173.5K |
| 2 | Hannah Brendan | COO, CCO, CBO | — | — |
| 3 | Thye Dirk | CEO, CMO, Dir | — | — |
Lynch Casey made no open-market trades at QNCX in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-19 | 2021-11-18 | QNCX | Quince Therapeutics, Inc. | Lynch Casey | CEO, Dir | M - OptEx | $0.46 | +60.0K | 109.9K | +120% | +$27.6K |
Purchase Sale Sale after option exercise All abbreviations